1-4 of 4
Yves Deugnier
Close
Sort by
Journal Articles

Deferasirox Improves Liver Pathology In β-Thalassemia Patients with Transfusional Iron Overload

Yves Deugnier, MD, Bruno Turlin, MD, PhD, Victor Dong, MD, Vanessa Giannone, BSN, Yiyun Zhang, PhD, Louis Griffel, MD, Pierre Brissot, MD
Journal: Blood
Blood (2010) 116 (21): 4274.
https://doi.org/10.1182/blood.V116.21.4274.4274
Published: 2010
Journal Articles

Semi-Quantitative Assessment of Hemosiderin Distribution Accurately Reflects Reductions in Liver Iron Concentration Following Therapy with Deferasirox (Exjade ® , ICL670) or Deferoxamine in Patients with Transfusion-Dependent Anemia.

Yves Deugnier, Bruno Turlin, Martine Ropert, Mohamed Bejaoui, Miranda Athanassiou-Metaxa, Holger Cario, Elliott Vichinsky, Herbert Opitz, Catherine Ressayre-Djaffer, Bertrand Rabault, John Ford
Journal: Blood
Blood (2005) 106 (11): 2708.
https://doi.org/10.1182/blood.V106.11.2708.2708
Published: 2005
Journal Articles

Altered Hepcidin Regulation in Hereditary Hemochromatosis and Dysmetabolic Hyperferritinemia.

Elizabeta Nemeth, Olivier Loreal, Caroline Le Lan, Martine Ropert, Marie-Bérengère Troadec, Lénaïck Detivaud, Christine Jard, Michele Pouchard, André Le Treut, Yves Deugnier, Tomas Ganz, Pierre Brissot
Journal: Blood
Blood (2005) 106 (11): 3590.
https://doi.org/10.1182/blood.V106.11.3590.3590
Published: 2005
Journal Articles

Redox active plasma iron in C282Y/C282Y hemochromatosis

Clinical Trials & Observations
Caroline Le Lan, Olivier Loréal, Tally Cohen, Martine Ropert, Hava Glickstein, Fabrice Lainé, Michel Pouchard, Yves Deugnier, André Le Treut, William Breuer, Z. Ioav Cabantchik, Pierre Brissot
Journal: Blood
Blood (2005) 105 (11): 4527–4531.
https://doi.org/10.1182/blood-2004-09-3468
Published: 2005